Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Giant cell arteritis complicated by aortic aneurysmal disease.

M Jack Cotlar1

  • 1Amerus Life Insurance Group, 9200 Keystone Crossing, Suite 800, Indianapolis, IN 46240-4603, USA. jack.cotlar@indianapolislife.com

Journal of Insurance Medicine (New York, N.Y.)
|July 19, 2006
PubMed
Summary

Giant cell arteritis (GCA) patients have similar mortality rates to the general population. Excess deaths may stem from aortic aneurysms, necessitating vigilant physician assessment and insurer awareness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abdominal aortic aneurysm repair--life insurance implications.

Journal of insurance medicine (New York, N.Y.)·2008
Same author

Myocardial bridging.

Journal of insurance medicine (New York, N.Y.)·2005
Same author

Attention deficit hyperactivity disorder (ADHD)--life insurance implications.

Journal of insurance medicine (New York, N.Y.)·2003
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Medical Insurance

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting large arteries.
  • While GCA treatment can be effective, long-term complications require ongoing monitoring.
  • Aortic aneurysms, particularly thoracic aortic dissection, are identified as potential serious complications of GCA.

Purpose of the Study:

  • To evaluate the mortality rates in patients diagnosed with giant cell arteritis (GCA).
  • To identify potential causes of excess mortality in GCA patients beyond the disease's direct inflammatory effects.
  • To highlight the importance of recognizing and managing aortic aneurysm risk in GCA survivors and inform insurance underwriting processes.

Main Methods:

  • Comparative analysis of mortality rates between GCA patients and age/sex-matched general populations.

Related Experiment Videos

  • Review of potential causes for excess mortality, focusing on cardiovascular complications.
  • Assessment of information transfer between treating physicians and insurer underwriting departments regarding patient risk factors.

    • Main Results:

    • Overall mortality in GCA patients is comparable to standard populations.
    • Excess mortality, when present, is often linked to aortic aneurysms, including thoracic aortic dissection.
    • Aneurysms can manifest years after GCA treatment cessation, underscoring the need for long-term surveillance.

    Conclusions:

    • Physicians must remain vigilant for thoracic and abdominal aortic aneurysms in GCA patients, even after treatment completion.
    • Medical records submitted to insurers may lack critical details, necessitating proactive information retrieval by underwriting departments.
    • Insurers need strategies to address potential data omissions and ensure accurate risk assessment for GCA patients.